SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Zonagen (zona) - good buy?

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Clase Azul who wrote (5133)8/7/1998 6:41:00 PM
From: Linda Kaplan  Read Replies (1) of 7041
 
A good week for the shorts. ZONA is seriously overvalued at this level. Even if they ever got Vasomax approved, the sales would be so poor this company would never be worth more than $6-8 a share, IMO.

After a bit of a flurry I would expect ZONA to continue down. Those who could have sold at 45 must be hurting now. I wouldn't be surprised if some brokers didn't lose their jobs over touting this poor stock. Any good research would have shown the drug didn't work well enough to be a money maker, IMO.

Linda
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext